| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |